-transparent.png){kind=logo}
Correlations between saliva and plasma concentrations of isosorbide dinitrate (ISDN), and its active metabolites, isosorbide 2-mononitrate (2-ISMN) and isosorbide 5-mononitrate (5-ISMN) were examined. In the case of 5-ISMN (r = 0.98, P less than 0.01), saliva concentrations are probably reliable indices of the plasma concentrations of this drug and their measurement should provide a useful non-invasive procedure to assess compliance during the clinical use of products containing either ISDN or 5-ISMN: it may also be helpful in assessing the clinical pharmacokinetics of 5-ISMN. Less satisfactory correlations were obtained for ISDN (r = 0.84) and 2-ISMN (r = 0.83).
Related Publications
I W Taylor, and
R M Major, and
L F Chasseaud, and
T Taylor
January 1990,
European journal of clinical pharmacology,
I W Taylor, and
R M Major, and
L F Chasseaud, and
T Taylor
September 1989,
International journal of clinical pharmacology, therapy, and toxicology,
I W Taylor, and
R M Major, and
L F Chasseaud, and
T Taylor
June 1985,
Ugeskrift for laeger,
I W Taylor, and
R M Major, and
L F Chasseaud, and
T Taylor
December 1976,
Clinical chemistry,
I W Taylor, and
R M Major, and
L F Chasseaud, and
T Taylor
April 1981,
Die Medizinische Welt,
I W Taylor, and
R M Major, and
L F Chasseaud, and
T Taylor
April 1981,
Die Medizinische Welt,
I W Taylor, and
R M Major, and
L F Chasseaud, and
T Taylor
November 1985,
Deutsche medizinische Wochenschrift (1946),
I W Taylor, and
R M Major, and
L F Chasseaud, and
T Taylor
May 1983,
The Journal of pharmacy and pharmacology,
I W Taylor, and
R M Major, and
L F Chasseaud, and
T Taylor
April 1981,
Die Medizinische Welt,
I W Taylor, and
R M Major, and
L F Chasseaud, and
T Taylor
April 1981,
Die Medizinische Welt,
